SAIPARENT — Sai Parenterals Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual income statement for Sai Parenterals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IAS	IAS	IAS
Status:	Final	Final	Final
Revenue
Total Revenue	968	1,538	1,631
Cost of Revenue
Gross Profit	374	562	669
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	839	1,315	1,314
Operating Profit	129	223	317
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	72.5	126	199
Provision for Income Taxes
Net Income After Taxes	43.8	84.2	144
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	43.8	84.2	145
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	43.8	84.2	145
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.986	1.9	3.27
Dividends per Share